Mitre Medical Corp.   Report issue

For profit Phase 2
Founded: Morgan Hill CA United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2018
NCT03600116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Mitre Medical Corp.

Active Ingredients

Drugs in Phase 2 Trials (1)

insulin lispro (humalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 1 (Phase 2)

Hypoglycemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1